Chiron Corporation

Wavesense, Inc.

The Director General of the National Institute of Health of Japan

Bruce D Irvine

Janice A Kolberg

Michael S Urdea

Tai-An Cha

Michael Houghton

Jang Hyun Han

Amy J Weiner

Eileen Beall

Qui-Lim Choo

George Kuo

Tatsuo Miyamura

Christopher C Feistel

Izumi Saito

Timothy M Bruemmer

Joyce A Running

Pawel Juraszek

Annular magnet housing

Fluid sequestration apparatus

Novel DNA probe sequences for detection of HIV in a sample in a solution phase sandwich hybridization assay are described. Amplified nucleic acid hybridization assays using the probes are exemplified.

HIV probes for use in solution phase sandwich hybridization assays

The present application features nucleic acid, peptide and antibody compositions relating to genotypes of hepatitis C virus and methods of using such compositions for diagnostic and therapeutic purposes.

HCV genomic sequences for diagnostics and therapeutics

Two new isolates of the Hepatitis C virus (HCV), J1 and J7, are disclosed. These new isolates comprise nucleotide and amino acid sequences which are distinct from the prototype HCV isolate, HCV1. Thus, J1 and J7 provide new polynucleotides and polypeptides for use, inter alia, in diagnostics, recombinant protein production and vaccine development.

Hepatitis C virus isolate polypeptides

Novel DNA probe sequences for detection of HBV in a sample in a solution phase sandwich hybridization assay are described. Amplified nucleic acid hybridization assays using the probes are exemplified.

HBV capture and amplifiers probes for use in solution phase sandwich

A new virus, Hepatitis C virus (HCV), which has proven to be the major etiologic agent of blood-borne NANBH, was discovered by Applicant. Reagents for isolating, amplifying, and detecting HCV polynucleotides are provided. These reagents are oligomers comprised of polynucleotide sequences which are capable of forming hybrid structures with HCV target polynucleotide sequences.

NANBV diagnostics: polynucleotides useful for screening for hepatitis C

A new virus, Hepatitis C virus (HCV), which has proven to be the major etiologic agent of blood-borne NANBH, was discovered by Applicant. Reagents for isolating, amplifying, and detecting HCV polynucleotides are provided. These reagents are oligomers containing polynucleotide sequences which are capable of forming hybrid structures with HCV target polynucleotide sequences.

Methods for detecting Hepatitis C virus using polynucleotides specific

Hepatitis C virus isolates

Growing community of inventors

Concord, CA, United States of America

Bruce D Irvine